Загрузка...
Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma
INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...
Сохранить в:
| Опубликовано в: : | Clin Lymphoma Myeloma Leuk |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/ https://ncbi.nlm.nih.gov/pubmed/31843543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|